BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26586471)

  • 1. Determination of affinity and efficacy of acetylcholinesterase inhibitors using isothermal titration calorimetry.
    Draczkowski P; Tomaszuk A; Halczuk P; Strzemski M; Matosiuk D; Jozwiak K
    Biochim Biophys Acta; 2016 May; 1860(5):967-974. PubMed ID: 26586471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening.
    Fabini E; Tramarin A; Bartolini M
    J Pharm Biomed Anal; 2018 Jun; 155():177-184. PubMed ID: 29635172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interaction studies of acetylcholinesterase with potential acetylcholinesterase inhibitors from the root of Rhodiola crenulata using molecular docking and isothermal titration calorimetry methods.
    Li FJ; Liu Y; Yuan Y; Yang B; Liu ZM; Huang LQ
    Int J Biol Macromol; 2017 Nov; 104(Pt A):527-532. PubMed ID: 28625836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Makhaeva GF; Kovaleva NV; Lushchekina SV; Rudakova EV; Boltneva NP; Proshin AN; Lednev BV; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2018 Nov; 483(1):369-373. PubMed ID: 30607741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
    Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
    J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
    J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE.
    Alonso D; Dorronsoro I; Rubio L; Muñoz P; García-Palomero E; Del Monte M; Bidon-Chanal A; Orozco M; Luque FJ; Castro A; Medina M; Martínez A
    Bioorg Med Chem; 2005 Dec; 13(24):6588-97. PubMed ID: 16230018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.
    Zurek E; Szymański P; Mikiciuk-Olasik E
    Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.
    Rathore R; Corr JJ; Lebre DT; Seibel WL; Greis KD
    Rapid Commun Mass Spectrom; 2009 Oct; 23(20):3293-300. PubMed ID: 19757451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations.
    Tanoli NU; Tanoli SAK; Ferreira AG; Mehmood M; Gul S; Monteiro JL; Vieira LCC; Venâncio T; Correa AG; Ul-Haq Z
    J Mol Model; 2018 Jul; 24(8):207. PubMed ID: 30008113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency determinations of acetylcholinesterase inhibitors using Ellman's reaction-based assay in screening: Effect of assay variants.
    Järvinen P; Vuorela P; Hatakka A; Fallarero A
    Anal Biochem; 2011 Jan; 408(1):166-8. PubMed ID: 20851093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor.
    Bartolini M; Cavrini V; Andrisano V
    J Chromatogr A; 2007 Mar; 1144(1):102-10. PubMed ID: 17134713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Martis EA; Chandarana RC; Shaikh MS; Ambre PK; D'Souza JS; Iyer KR; Coutinho EC; Nandan SR; Pissurlenkar RR
    J Biomol Struct Dyn; 2015; 33(5):1107-25. PubMed ID: 24905476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase capillary enzyme reactor for screening and characterization of selective inhibitors.
    da Silva JI; de Moraes MC; Vieira LC; Corrêa AG; Cass QB; Cardoso CL
    J Pharm Biomed Anal; 2013 Jan; 73():44-52. PubMed ID: 22391555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of four neonicotinoid active ingredients on acetylcholine esterase activity.
    Győri J; Farkas A; Stolyar O; Székács A; Mörtl M; Vehovszky Á
    Acta Biol Hung; 2017 Dec; 68(4):345-357. PubMed ID: 29262703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.